RTW INVESTMENTS, LP - MILESTONE PHARMACEUTICALS IN ownership

MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 37 filers reported holding MILESTONE PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of MILESTONE PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$10,093,916
+8.8%
3,256,1020.0%0.21%
+20.3%
Q2 2023$9,279,891
-27.7%
3,256,1020.0%0.18%
-33.7%
Q1 2023$12,829,042
-24.9%
3,256,102
-24.5%
0.27%
-23.5%
Q4 2022$17,087,804
-56.9%
4,315,1020.0%0.35%
-61.8%
Q3 2022$39,656,000
+49.4%
4,315,1020.0%0.91%
+33.2%
Q2 2022$26,538,000
-4.2%
4,315,1020.0%0.69%
+19.7%
Q1 2022$27,703,000
-2.0%
4,315,1020.0%0.57%
+38.7%
Q4 2021$28,264,000
+14.7%
4,315,1020.0%0.41%
+11.0%
Q3 2021$24,639,000
+3.8%
4,315,1020.0%0.37%
+3.9%
Q2 2021$23,733,000
-5.0%
4,315,1020.0%0.36%
-8.2%
Q1 2021$24,984,000
-13.6%
4,315,1020.0%0.39%
-19.6%
Q4 2020$28,911,000
-8.5%
4,315,1020.0%0.48%
-36.3%
Q3 2020$31,587,000
+93.7%
4,315,1020.0%0.76%
+65.8%
Q2 2020$16,311,000
+105.4%
4,315,1020.0%0.46%
+34.2%
Q1 2020$7,940,000
-87.5%
4,315,102
+9.0%
0.34%
-85.7%
Q4 2019$63,372,000
-0.7%
3,958,264
+12.4%
2.39%
-37.0%
Q3 2019$63,819,000
-29.8%
3,521,8560.0%3.80%
-21.9%
Q2 2019$90,967,0003,521,8564.86%
Other shareholders
MILESTONE PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Novo Holdings A/S 2,530,585$16,955,0000.73%
Ikarian Capital, LLC 1,836,545$12,305,0000.54%
Boxer Capital, LLC 2,477,194$16,597,0000.53%
RTW INVESTMENTS, LP 4,315,102$28,911,0000.48%
RA Capital Management 2,327,714$15,596,0000.22%
Orbimed Advisors 2,493,109$16,704,0000.15%
PURA VIDA INVESTMENTS, LLC 450,000$3,015,0000.11%
SUVRETTA CAPITAL MANAGEMENT, LLC 851,291$5,704,0000.08%
Anson Funds Management LP 50,113$336,0000.07%
Tekla Capital Management LLC 253,610$1,699,0000.06%
View complete list of MILESTONE PHARMACEUTICALS IN shareholders